임상시험

C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study.

NCT: NCT03311451 · ACTIVE_NOT_RECRUITING

NCT IDNCT03311451

상태ACTIVE_NOT_RECRUITING

시작일2023-01-16

완료2026-12-18

SponsorMerit Medical Systems, Inc. (INDUSTRY)

First posted2017-10-17

Last updated2026-05-22

간략 요약

The primary objective is to determine the safety and efficacy of the C2 CryoBalloon 180 Ablation System ("CryoBalloon 180") used at decreasing doses in ablation naïve patients with low- or high-grade dysplastic Barrett's Esophagus (BE) or with residual BE after resection of dysplasia or early adenocarcinoma.

공식 출처

ClinicalTrials.gov에서 보기 →

데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.